165 related articles for article (PubMed ID: 15017663)
1. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
Ioannou GN; Kowdley KV
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
[No Abstract] [Full Text] [Related]
2. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
3. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
4. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
[TBL] [Abstract][Full Text] [Related]
5. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
6. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
7. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.
Corengia C; Galimberti S; Bovo G; Vergani A; Arosio C; Mariani R; Redaelli A; Riva A; Cestari C; Pozzi M; Valsecchi MG; Piperno A
Am J Clin Pathol; 2005 Dec; 124(6):846-53. PubMed ID: 16416733
[TBL] [Abstract][Full Text] [Related]
8. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
10. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
11. HFE genotyping: maximising the value for hemochromatosis patients and families.
Bassett ML
J Gastroenterol Hepatol; 2010 Jul; 25(7):1186-8. PubMed ID: 20594244
[No Abstract] [Full Text] [Related]
12. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hemochromatosis protein, HFE, alters transferrin recycling process in human hepatoma cells.
Ikuta K; Fujimoto Y; Suzuki Y; Tanaka K; Saito H; Ohhira M; Sasaki K; Kohgo Y
Biochim Biophys Acta; 2000 Apr; 1496(2-3):221-31. PubMed ID: 10771090
[TBL] [Abstract][Full Text] [Related]
14. [HFE gene mutations and risk of hepatocellular carcinoma].
Solís Herruzo JA; Solís Muñoz P
Rev Esp Enferm Dig; 2007 Jul; 99(7):369-75. PubMed ID: 17973579
[No Abstract] [Full Text] [Related]
15. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
18. Iron metabolism and the role of HFE gene polymorphisms in Wilson disease.
Pfeiffenberger J; Gotthardt DN; Herrmann T; Seessle J; Merle U; Schirmacher P; Stremmel W; Weiss KH
Liver Int; 2012 Jan; 32(1):165-70. PubMed ID: 22098612
[TBL] [Abstract][Full Text] [Related]
19. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
20. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]